Apimeds unit MindWave Innovations to deploy MindChain for AQUAEChain
APUS•MindWave Innovations, a unit of Apimeds Pharmaceuticals US, signed a 12-month technology services deal with AQUAE Holdings to power AQUAEChain. The agreement includes a quarterly allocation to MindWave equal to 20% of ALCI Credits issued and outstanding on the platform.
1. Technology services deal
MindWave will deploy its MindChain blockchain to support the issuance, tracking, verification, trading and retirement of insured ALCI Credits on AQUAEChain. The agreement took effect Sept. 14, 2026, and the parties expect to negotiate a five-year services arrangement after the initial term.
